Article info
PDFOriginal article
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial
- Professor H Schmidt, Dr von Hauner Children’s Hospital, University of Munich, Lindwurmstr. 4, 80337 Munich, Germany; heinrich.schmidt{at}med.uni-muenchen.de
Citation
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial
Publication history
- Received July 31, 2008
- Revised September 29, 2008
- Accepted October 2, 2008
- First published October 23, 2008.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group